课题基金 / 基金详情

项目摘要

项目成果

Robert Walter Buckheit的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结(见说明): 拟议的项目包括用单一药剂开发杀微生物剂产品和独特地输送到阴道和直肠间隔的复合杀微生物剂产品,以及杀微生物剂科学进步的复杂相互作用,其中活性杀菌剂将被用作工具,以更好地 了解杀微生物剂的剂量、在外植体、非人类灵长类动物和人类中的药代动力学和药效学,以及可接受性/使用者感知。产品开发成分由双重作用的Entry和非核苷逆转录酶抑制剂IQP-0528(一种具有抗HIV-1临床毒株的亚纳摩尔活性的嘧啶二酮)单独使用和与替诺福韦联合使用。 多凝胶(DuoGels)凝胶和智能栓剂/阴道(智能栓剂)递送工具,可在阴道和直肠间给药。我们相信在产品开发(新的杀微生物剂、组合产品、长效给药技术、双室给药技术)和杀微生物剂科学(剂量估计、药代动力学、 药效学、体外、体外和体内建模、精液和阴道液的影响、可接受性测试方法)使这一建议既具有内在的新颖性,又对杀微生物剂科学领域关于开发下一代杀微生物剂产品具有重要意义。总体而言,该项目还提供了开发新的PK/PD分析、新的单一和组合产品、新的给药策略和新的杀微生物剂开发进展,以更好地了解和优先开发和使用杀微生物剂产品。行政核心将在确保本合作协议中包括的各种项目和核心顺利整合方面发挥关键和必要的作用 研究计划。该项目的成功实施需要各个项目、核心和公司合作伙伴之间的高度沟通和互动。行政核心将负责管理和加强参与科学小组之间的这种建设性和协同作用。
英文摘要
PROJECT SUMMARY (See instructions): The proposed Project includes a complex interplay of both microbicide product development with single agent and combination microbicide products uniquely delivered to both the vaginal and rectal compartments, as well as microbicide science advancement in which the active microbicides will be utilized as tools to better understand microbicide dosing, pharmacokinetics and pharmacodynamics in explants, nonhuman primates and humans, and acceptability/user perception. The product development components consist of the dual acting entry and nonnucleoside reverse transcriptase inhibitor IQP-0528 (a pyrimidinedione with subnanomolar activity against clinical strains of HIV-1) used alone and in combination with tenofovir in dual compartment (DuoGels) gels and smart suppository/pessary (Smart Suppository) delivery vehicles that will enable dosing in both vaginal and rectal compartments. We believe the potential advancements in product development (new microbicide agents, combination products, long lasting delivery technology, dual compartment delivery technology) and microbicide science (dosing estimation, pharmacokinetics, pharmacodynamics, in vitro, ex vivo, and in vivo modeling, effects of seminal and vaginal fluids, acceptability testing methods) make this proposal both inherently novel and important to the field of microbicide science in regard to the development of the next generation of microbicide products. In whole, the Project also provides for the development of novel PK/PD assays, novel single and combination products, novel delivery strategies, and novel microbicide development advancements to better understand and prioritize the development and use of microbicide products. The Administrative Core will play a critical and essential role in ensuring the smooth integration of the various Projects and Cores included in this cooperative agreement research program. The successful performance of this Project requires a high degree of communication and interaction between the various Projects, the Cores, and the Corporate Partner. The Administrative Core will be responsible for managing and enhancing this constructive and synergistic interplay between the participating scientific groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Critical Path IND-enabling Studies, Regulatory, and Product Development
  • 批准号:
    8405106
  • 项目类别:
  • 资助金额:
    $94.2万
  • 财政年份:
    2012
  • 负责人:
    Robert Walter Buckheit
  • 依托单位:
Determination of Dosing Concentrations of Formulated APIs using the MTSA
  • 批准号:
    8404125
  • 项目类别:
  • 资助金额:
    $33.75万
  • 财政年份:
    2012
  • 负责人:
    Robert Walter Buckheit
  • 依托单位:
Development and Evaluation of Dual Compartment Combination Microbicides
  • 批准号:
    8699496
  • 项目类别:
  • 资助金额:
    $287.64万
  • 财政年份:
    2012
  • 负责人:
    Robert Walter Buckheit
  • 依托单位:
Development and Evaluation of Dual Compartment Combination Microbicides
  • 批准号:
    8862358
  • 项目类别:
  • 资助金额:
    $244.32万
  • 财政年份:
    2012
  • 负责人:
    Robert Walter Buckheit
  • 依托单位:
海外基金